Search by Drug Name or NDC
NDC 65162-0339-85 Dapsone 50 mg/g Details
Dapsone 50 mg/g
Dapsone is a TOPICAL GEL in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals LLC. The primary component is DAPSONE.
MedlinePlus Drug Summary
Dapsone topical is used to treat acne in children, teenagers, and adults. Dapsone is in a class of medications called sulfone antibiotics. It works by slowing or stopping the growth of bacteria and to decrease inflammation.
Related Packages: 65162-0339-85Last Updated: 04/28/2024
MedLinePlus Full Drug Details: Dapsone Topical
Product Information
| NDC | 65162-0339 |
|---|---|
| Product ID | 65162-339_664ba234-0325-42ff-b33a-c507f63b70d5 |
| Associated GPIs | |
| GCN Sequence Number | 061136 |
| GCN Sequence Number Description | dapsone GEL (GRAM) 5 % TOPICAL |
| HIC3 | L5H |
| HIC3 Description | ACNE AGENTS,TOPICAL |
| GCN | 27312 |
| HICL Sequence Number | 004177 |
| HICL Sequence Number Description | DAPSONE |
| Brand/Generic | Generic |
| Proprietary Name | Dapsone |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Dapsone |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | GEL |
| Route | TOPICAL |
| Active Ingredient Strength | 50 |
| Active Ingredient Units | mg/g |
| Substance Name | DAPSONE |
| Labeler Name | Amneal Pharmaceuticals LLC |
| Pharmaceutical Class | Sulfone [EPC], Sulfones [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA209890 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 65162-0339-85 (65162033985)
| NDC Package Code | 65162-339-85 |
|---|---|
| Billing NDC | 65162033985 |
| Package | 1 TUBE in 1 CARTON (65162-339-85) / 60 g in 1 TUBE |
| Marketing Start Date | 2023-10-24 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |